CREB1 and diabetic cardiomyopathy: Disease modeling and phenotypic drug screening for diabetic cardiomyopathy has revealed the potential for glucocorticoid receptor involvement [60], diabetic cardiomyopathy upregulation of CREB [61], and the E2F family transcription factors, including E2F1 [62].